Výsledky vyhledávání - "Revonda Mehovic"

Abstract 1161: EZH2 inhibitor tazemetostat demonstrates activity in preclinical models of Bruton's tyrosine kinase inhibitor-resistant relapsed/refractory mantle cell lymphoma

Autor: Jeremy C. Cunniff, Alejandra Raimondi, Crag Markwood, Weiqing Chen, Cuyue Tang, Arleide Lee, Revonda Mehovic, Veronica Gibaja, Vania Estanek, Daniel T. Dransfield, Jeffrey A. Keats

Publikováno v: Cancer Research. 81:1161-1161

Tazemetostat (EZM6438) is a potent, orally bioavailable small molecule inhibitor of EZH2, the enzymatic subunit of the polycomb repressive complex 2, which has been approved for treatment of epithelioid sarcoma and relapsed/refractory follicular lymp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5ef5d73cd93a0b173b274936d18d6713
https://doi.org/10.1158/1538-7445.am2021-1161

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání